Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
The worldwide emergence of plasmid-mediated quinolone resistance.
- A. Robicsek, G. Jacoby, D. Hooper
- BiologyThe Lancet. Infectious diseases
- 1 October 2006
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
- J. Strahilevitz, G. Jacoby, D. Hooper, A. Robicsek
- BiologyClinical Microbiology Reviews
- 1 October 2009
TLDR
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
- A. Robicsek, J. Strahilevitz, D. Hooper
- BiologyNature Medicine
- 2006
TLDR
qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States
- A. Robicsek, J. Strahilevitz, D. Sahm, G. Jacoby, D. Hooper
- Medicine, BiologyAntimicrobial Agents and Chemotherapy
- 1 August 2006
TLDR
Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, China
- Minggui Wang, J. Tran, G. Jacoby, Yingyuan Zhang, Fu Wang, D. Hooper
- BiologyAntimicrobial Agents and Chemotherapy
- 1 July 2003
TLDR
Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme
- Chinsu Park, A. Robicsek, G. Jacoby, D. Sahm, D. Hooper
- Biology, MedicineAntimicrobial Agents and Chemotherapy
- 5 September 2006
TLDR
Mechanisms of fluoroquinolone resistance.
- D. Hooper
- Biology, MedicineDrug resistance updates : reviews and…
- 1 February 1999
Mechanisms of bacterial resistance to fluoroquinolones fall into two principal categories, alterations in drug target enzymes and alterations that limit permeation of drug to the target, both…
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.
TLDR
qnrB, Another Plasmid-Mediated Gene for Quinolone Resistance
TLDR
Emerging mechanisms of fluoroquinolone resistance.
- D. Hooper
- Biology, MedicineEmerging infectious diseases
- 1 March 2001
Broad use of fluoroquinolones has been followed by emergence of resistance, which has been due mainly to chromosomal mutations in genes encoding the subunits of the drugs' target enzymes, DNA gyrase…
...
...